Table 5.
Associations (standardized betas) between exposure metrics and log10-transformed oxidative stress and antioxidant biomarkers concentrations in the EXPERIVA study.
| Exposure metrics | TAC | SOD | GST | CAT | aMT6s | MDA | 8-OHdG | 8-IP |
|---|---|---|---|---|---|---|---|---|
| All—ID2W no buffer | −0.020 | −0.134 | −0.004 | 0.144 | −0.128 | 0.092 | −0.237* | −0.024 |
| All—ID2W 10 km | −0.031 | −0.150 | −0.020 | 0.172 | −0.142 | 0.093 | −0.236* | −0.014 |
| All—ID2W 5 km | −0.036 | −0.153 | −0.023 | 0.182✝ | −0.144 | 0.089 | −0.242* | −0.008 |
| All—Density 10 km | 0.036 | −0.118 | 0.038 | −0.032 | −0.049 | 0.080 | −0.103 | −0.086 |
| All—Density 5 km | 0.018 | −0.148 | −0.007 | 0.071 | −0.119 | 0.068 | −0.226✝ | −0.080 |
| UOG—ID2W no buffer | −0.002 | −0.228* | −0.017 | 0.115 | −0.146 | 0.030 | −0.281* | −0.090 |
| UOG—ID2W 10 km | −0.0003 | −0.224* | −0.028 | 0.142 | −0.163 | 0.038 | −0.290* | −0.074 |
| UOG—ID2W 5 km | 0.002 | −0.218* | −0.031 | 0.152 | −0.173✝ | 0.043 | −0.299* | −0.066 |
| UOG—Density 10 km | −0.008 | −0.196✝ | 0.034 | −0.052 | 0.006 | 0.003 | −0.075 | −0.114 |
| UOG—Density 5 km | −0.007 | −0.184 | −0.013 | 0.063 | −0.099 | 0.019 | −0.205✝ | −0.090 |
| UOG—PAD no buffer | 0.020 | −0.049 | 0.000 | −0.138 | 0.134 | 0.022 | 0.099 | −0.060 |
| UOG—PAD 10 km | 0.074 | −0.015 | 0.015 | −0.097 | 0.121 | 0.078 | 0.107 | 0.003 |
| UOG—PAD 5 km | 0.106 | −0.030 | 0.049 | −0.095 | 0.071 | 0.077 | 0.078 | −0.011 |
| UOG—DRILL no buffer | −0.024 | −0.034 | −0.048 | −0.134 | 0.153 | 0.040 | 0.062 | −0.072 |
| UOG—DRILL 10 km | 0.026 | 0.008 | −0.027 | −0.097 | 0.137 | 0.093 | 0.083 | −0.009 |
| UOG—DRILL 5 km | 0.072 | −0.008 | 0.019 | −0.097 | 0.089 | 0.092 | 0.047 | −0.031 |
| UOG—STIM no buffer | −0.052 | −0.035 | −0.031 | −0.076 | 0.135 | 0.084 | 0.044 | −0.074 |
| UOG—STIM 10 km | −0.034 | −0.013 | −0.021 | −0.055 | 0.113 | 0.115 | 0.062 | −0.027 |
| UOG—STIM 5 km | −0.025 | −0.026 | 0.008 | −0.041 | 0.078 | 0.119 | 0.043 | −0.026 |
| UOG—PROD no buffer | 0.079 | −0.142 | 0.070 | −0.113 | 0.025 | −0.115 | 0.041 | −0.053 |
| UOG—PROD 10 km | 0.094 | −0.133 | 0.060 | −0.087 | 0.013 | −0.110 | 0.049 | −0.023 |
| UOG—PROD 5 km | 0.094 | −0.119 | 0.062 | −0.072 | −0.013 | −0.098 | 0.041 | 0.003 |
| Conv—ID2W no buffer | −0.035 | 0.085 | 0.018 | 0.104 | −0.028 | 0.132 | −0.033 | 0.090 |
| Conv—ID2W 10 km | −0.066 | 0.063 | 0.006 | 0.126 | −0.027 | 0.135 | −0.008 | 0.098 |
| Conv—ID2W 5 km | −0.086 | 0.050 | 0.006 | 0.137 | −0.011 | 0.125 | −0.002 | 0.103 |
| Conv—Density 10 km | 0.068 | 0.080 | 0.014 | 0.020 | −0.094 | 0.123 | −0.061 | 0.019 |
| Conv—Density 5 km | 0.072 | 0.036 | 0.014 | 0.049 | −0.107 | 0.153✝ | −0.144 | −0.004 |
| Acetone | 0.032 | 0.085 | 0.017 | 0.071 | −0.002 | 0.106 | 0.062 | 0.023 |
| Chloroform | −0.159 | −0.127 | −0.147 | −0.106 | 0.060 | −0.017 | −0.138 | −0.143 |
| 1,4-Dioxane | −0.055 | 0.003 | 0.074 | 0.075 | 0.066 | −0.209* | 0.185 | −0.078 |
| Decanal | 0.121 | −0.059 | 0.150 | 0.078 | −0.037 | −0.037 | −0.182 | 0.019 |
| Hexanal | 0.035 | −0.101 | 0.015 | −0.034 | −0.249* | −0.049 | −0.050 | 0.165✝ |
| mp-Xylene | −0.028 | 0.003 | −0.042 | 0.153 | −0.095 | 0.048 | 0.021 | −0.085 |
| o-Xylene | −0.022 | 0.002 | −0.040 | 0.148 | −0.115 | 0.039 | −0.007 | −0.075 |
| Styrene | −0.015 | 0.025 | −0.045 | 0.057 | −0.086 | 0.085 | 0.002 | −0.102 |
| BTEX | 0.054 | −0.004 | 0.062 | −0.066 | −0.014 | 0.113 | −0.068 | −0.097 |
Sample size = 85. Pooled urine samples run in duplicate for assays. Significance is indicated by P-value symbols (*P ≤ 0.05; ✝P ≤ 0.10). Standardized betas were calculated using multiple linear regression models. TAC, SOD, GST, and CAT models were standardized for age, gestational week at the time of recruitment, smoking status, Indigenous status, and urinary creatinine. aMT6 models were adjusted for age, gestational week at the time of recruitment, smoking status, Indigenous status, urinary creatinine, and time of sample collection. MDA, 8-IP, and 8-OHdG models were adjusted for melatonin, age, gestational week at the time of recruitment, smoking status, Indigenous status and urinary creatinine.